Nisa Investment Advisors
DYN icon

Nisa Investment Advisors’s Dyne Therapeutics DYN Stock Holding History

Nisa Investment Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.9K Sell
2,972
-7,527
-72% -$130K ﹤0.01% 1635
2025
Q4 		$205K Buy
10,499
+9,550
+1,006% +$181K ﹤0.01% 1225
2025
Q3 		$12K Sell
949
-76
-7% -$867 ﹤0.01% 2213
2025
Q2 		$9.76K Sell
1,025
-475
-32% -$5.23K ﹤0.01% 2277
2025
Q1 		$15.7K Buy
1,500
+790
+111% +$11.3K ﹤0.01% 1978
2024
Q4 		$16.7K Sell
710
-59
-8% -$1.75K ﹤0.01% 1991
2024
Q3 		$27.6K Buy
769
+26
+3% +$1.03K ﹤0.01% 1807
2024
Q2 		$26.2K Buy
743
+669
+904% +$19.4K ﹤0.01% 1852
2024
Q1 		$2.1K Buy
+74
New +$1.67K ﹤0.01% 2226
2023
Q4 		– Sell
-35
Closed -$314 – 2672
2023
Q3 		$314 Sell
35
-10
-22% -$108 ﹤0.01% 2604
2023
Q2 		$506 Hold
45
– – ﹤0.01% 2557
2023
Q1 		$1K Hold
45
– – ﹤0.01% 2374
2022
Q4 		$1K Buy
+45
New +$521 ﹤0.01% 2422
2022
Q3 		– Sell
-347
Closed -$2K – 2595
2022
Q2 		$2K Sell
347
-14,000
-98% -$96.4K ﹤0.01% 2343
2022
Q1 		$138K Buy
14,347
+14,000
+4,035% +$119K ﹤0.01% 1508
2021
Q4 		$3K Sell
347
-477
-58% -$6.7K ﹤0.01% 2111
2021
Q3 		$13 Sell
824
-6,682
-89% -$118K ﹤0.01% 2171
2021
Q2 		$158 Hold
7,506
– – ﹤0.01% 1494
2021
Q1 		$117 Hold
7,506
– – ﹤0.01% 1681
2020
Q4 		$158K Buy
+7,506
New +$148K ﹤0.01% 1567

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Nisa Investment Advisors's DYN Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Dyne Therapeutics (DYN) stake by 72% in Q1 2026, selling an estimated $130K and leaving 2,972 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1635.

Nisa Investment Advisors first reported a position in DYN in Q4 2020 and has held it in 20 quarters since. The position peaked at $205K in Q4 2025. 228 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Nisa Investment Advisors held 2,972 shares of Dyne Therapeutics worth $53.9K as of Q1 2026.
  • Nisa Investment Advisors sold 7,527 Dyne Therapeutics shares in Q1 2026, an estimated $130K.
  • Dyne Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1635 holding.
  • Nisa Investment Advisors first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Nisa Investment Advisors's Dyne Therapeutics position peaked at $205K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.